YFY Biotech Management Company
Venture capitalTaipei · Seed–Series B · 1 people tracked
Investment thesis
The firm operates as a biotech incubator, investment and management-advisory team created by Taiwan's YFY Group. Established in 2003, it raised the Sun Way Biotech venture capital fund in 2005. Its advisory team brings cross-disciplinary experience spanning industry, government, academia, research and investment, with expertise in biomedical technology, intellectual-property management, policy and regulatory affairs, operations, finance and capital raising. It supports biotech companies through incubation, investment and hands-on management guidance.
Source: firm website, verified Aug 17, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 1 of 2 portfolio companiesBiotech ×1Healthtech ×1Medical Devices ×1
HQs:Taiwan×1
Investments · 2 tracked
founders shown can be your intro pathTaiMed Biologics is a Taiwan-based biopharmaceutical company that develops monoclonal antibody therapies for HIV, including the long-acting TMB-365/TMB-380 combination and the CD4-targeted ADC platform extending into autoimmune diseases.
BiotechHealthtechMedical Devices
Jimmy Chang(CEO)
Taiwan biotech (ticker 4157) partnering with Insilico Medicine on AI-driven drug development for CKD anemia; its Pixavir flu drug was approved in mainland China.
Frequently asked questions
- What stage does YFY Biotech Management Company invest at?
- YFY Biotech Management Company invests at the Seed, Series A, Series B stages.
- What sectors does YFY Biotech Management Company focus on?
- YFY Biotech Management Company focuses on Biotech, Healthtech, Medical Devices.
- Where is YFY Biotech Management Company located?
- YFY Biotech Management Company is headquartered in Taipei, TW.
Similar investors
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
Sofinnova is an investment firm that partners with biotech companies from inception through growth, supporting drug development, the regulatory process, company building, and IPO.
Kaiser Permanente Ventures is the corporate venture capital arm investing in healthcare companies that address real needs and deliver value for patients, providers, healthcare delivery systems, and communities.
Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, backing companies across all stages of growth. It applies a data science-driven approach to invest in businesses leveraging biology and big data to transform healthcare.
Korea Investment Partners is a South Korea-based venture capital firm that invests across multiple stages from early-stage startups through growth and buyout transactions, including venture debt and mezzanine financing. The firm operates across venture capital, middle market, and growth equity investment categories.